488 related articles for article (PubMed ID: 19236640)
1. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
[TBL] [Abstract][Full Text] [Related]
2. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
Karavitaki N; Warner JT; Marland A; Shine B; Ryan F; Arnold J; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 May; 64(5):556-60. PubMed ID: 16649976
[TBL] [Abstract][Full Text] [Related]
3. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
4. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
Chung TT; Drake WM; Evanson J; Walker D; Plowman PN; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2005 Sep; 63(3):274-9. PubMed ID: 16117814
[TBL] [Abstract][Full Text] [Related]
5. Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
Chung TT; Evanson J; Walker D; Akker SA; Besser GM; Monson JP; Grossman AB; Drake WM
Clin Endocrinol (Oxf); 2008 Jun; 68(6):965-9. PubMed ID: 18031317
[TBL] [Abstract][Full Text] [Related]
6. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.
Karavitaki N; Brufani C; Warner JT; Adams CB; Richards P; Ansorge O; Shine B; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2005 Apr; 62(4):397-409. PubMed ID: 15807869
[TBL] [Abstract][Full Text] [Related]
7. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
8. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
9. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy.
van den Bergh AC; van den Berg G; Schoorl MA; Sluiter WJ; van der Vliet AM; Hoving EW; Szabó BG; Langendijk JA; Wolffenbuttel BH; Dullaart RP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):863-9. PubMed ID: 17197121
[TBL] [Abstract][Full Text] [Related]
10. Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors.
Jostel A; Mukherjee A; Hulse PA; Shalet SM
Clin Endocrinol (Oxf); 2005 Jun; 62(6):698-705. PubMed ID: 15943832
[TBL] [Abstract][Full Text] [Related]
11. Changes in the volume of residual pituitary adenomas in patients with adult-onset growth hormone deficiency during replacement therapy with the recombinant human growth hormone.
Finkenstedt G; Höfle G; Pallua A; Sailer U; Gasser RW
Wien Klin Wochenschr; 1999 Nov; 111(21):887-90. PubMed ID: 10599151
[TBL] [Abstract][Full Text] [Related]
12. Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
Reddy R; Cudlip S; Byrne JV; Karavitaki N; Wass JA
Eur J Endocrinol; 2011 Nov; 165(5):739-44. PubMed ID: 21900406
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
[TBL] [Abstract][Full Text] [Related]
14. The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas.
O'Sullivan EP; Woods C; Glynn N; Behan LA; Crowley R; O'Kelly P; Smith D; Thompson CJ; Agha A
Clin Endocrinol (Oxf); 2009 Nov; 71(5):709-14. PubMed ID: 19302582
[TBL] [Abstract][Full Text] [Related]
15. What is the natural history of nonoperated nonfunctioning pituitary adenomas?
Karavitaki N; Collison K; Halliday J; Byrne JV; Price P; Cudlip S; Wass JA
Clin Endocrinol (Oxf); 2007 Dec; 67(6):938-43. PubMed ID: 17692109
[TBL] [Abstract][Full Text] [Related]
16. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
[TBL] [Abstract][Full Text] [Related]
17. Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth.
Greenman Y; Tordjman K; Osher E; Veshchev I; Shenkerman G; Reider-Groswasser II; Segev Y; Ouaknine G; Stern N
Clin Endocrinol (Oxf); 2005 Jul; 63(1):39-44. PubMed ID: 15963059
[TBL] [Abstract][Full Text] [Related]
18. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
19. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
[TBL] [Abstract][Full Text] [Related]
20. Gamma knife radiosurgery for endocrine-inactive pituitary adenomas.
Liscák R; Vladyka V; Marek J; Simonová G; Vymazal J
Acta Neurochir (Wien); 2007 Oct; 149(10):999-1006; discussion 1006. PubMed ID: 17676409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
